期刊文献+

C-反应蛋白在大鼠自体静脉移植动脉化中的作用

Effect of C-reactive protein on autologous vein graft arterial of rat
下载PDF
导出
摘要 目的探讨C-反应蛋白(CRP)在自体静脉移植动脉化中是否参与血管重塑过程。方法通过建立自体静脉移植动脉化模型,CBS3830加以干预,应用ELISA法检测CRP水平;术后1周和2周检测内膜厚度;Western blot法检测p38、P-p38表达。结果 0~2周各时间点内,模型组CRP水平呈逐渐上升趋势,假手术组呈先上升后下降趋势,两组比较差异有统计学意义(P<0.05),在1、2周时,药物组与模型组、假手术组比较差异均有统计学意义(P<0.05)。药物组内膜增生与模型组比较差异有统计学意义(P<0.01)。1周后p38、P-p38产物表达药物组明显低于模型组及假手术组(P<0.01,P<0.05)。结论 CRP参与了自体静脉移植动脉化血管重塑过程;但可能与p38MAPK通路无关,CBS3830对其没有起到明显的抑制作用。 Objective To discuss if C-reactive protein (CRP) involved in vascular remodeling in the process of venous vein graft arterialization. Methods Interfection with CBS3830, enzyme-linked immunosorbent assay (EL- SIA) was used to detect the serum levels of CRP. Detected the intima thickness at 1,2 week in each group. Western blot was used to detect the expression of p38, p-p38. Results At 0 - 2 weeks each time point, CRP levels in the model group showed a gradual upward trend, while that in the sham group increased at first, and then decreased, with the significant difference between two groups (P 〈 0.05 ). Compared with the sham group and model group, the drug group had significant differences at 1 week and 2 weeks time ( P 〈 0.05 ). Intimal hyperplasia of drug group,compared with the model group has differences (P 〈0.01 ). 1 week later shows the product of p38 and P-p38 expression, drug group was significantly lower than the other two groups ( P 〈 0.01 ). Conclusion CRP take part in the autologous vein graft arterial vascular remodeling process; which may not be related with the p38MAPK pathway for CBS3830 does not play a significant inhibiting effect.
出处 《安徽医科大学学报》 CAS 北大核心 2011年第12期1257-1259,共3页 Acta Universitatis Medicinalis Anhui
基金 安徽省科技厅重点项目(编号:07020303071)
关键词 P38MAPK抑制剂 静脉动脉化 内膜增生 CRP p38 静脉桥 p38MAPK inhibitor vein arterialization vein grafts CRP p38 vein-bridge
  • 相关文献

参考文献12

  • 1Tataru M C, Heinrich J, Junker R, et al. C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris[J]. Eur Heart J,2000,21 (12) :1000 -8.
  • 2Hsieh Y H, Wu T T, Huang C Y. p38 mitogen-aetivated protein kinase pathway is involved in protein kinase C alpha-regulated invasion inhuman hepatoeellular carcinoma cells [J]. Cancer Res, 2007,67(9) :4320 -7.
  • 3Zou Y, Dietrich H, Hu Y, et al. Mouse model of venous bypass graft arteriosclerosis[J]. Am J Pathol, 1998,153 (4) : 1301 - 10.
  • 4赵智伟,葛建军,周正春,刘永志,邬松,周经月.改良cuff法和间断缝合法在静脉桥狭窄模型中的应用[J].安徽医科大学学报,2010,45(4):474-476. 被引量:4
  • 5Gould J M, Weiser J N. Expression of C-reactive protein in the human respiratory tract[J]. Infect Immun, 2007,69 (3) :1747 - 54.
  • 6Ridker P M, Hennekens C H, Buring J E, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women[J]. N Engl J Med, 2000, 342(12) : 836 - 43.
  • 7Yasojima K, Schwab C, McGeer E G, et al. Generation of C-reactive protein and complement components in atherosclerotic plaques[J]. Am J Pathol, 2005,158(3) :1039 -51.
  • 8Kobayashi S, Inoue N, Mori T, et al. Interaction of oxidative stress and inflammatory response in coronary plaque instability: important role of C-reactive protein[J]. Arterioscler Thromb Vasc Biol, 2005, 23(8) :1398 -404.
  • 9Torzewski M, Rist C, Zwaka T P, et al. C-reactive protein in the arterial intima : Role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis [ J ]. Arterioscler Thromb Vasc Biol, 2008, 20(9):2094-9.
  • 10Jabs W J, Theissing E, Nitschke M, et al. Local generation of C-reactive protein in diseased coronary artery venous bypass grafts and normal vascular tissue[J]. Circulation, 2005,108 ( 12 ) : 1428 -31.

二级参考文献10

  • 1孙洪涛,祝家镇.根据损伤组织中C─反应蛋白的含量及分布推断损伤时间[J].中国法医学杂志,1995,10(2):86-89. 被引量:1
  • 2Bourassa M G.Fate of venous grafts:the past,the present,and the future[J].J Am Coll Cardiol,1991,17(5):1081 -3.
  • 3Fitzgibbon G M,Kafka H P,Leach A J,et al.Coronary bypass graft fate and patient outcome:angiographic follow-up of 5065 grafts related to survival and reoperation in 1388 patients during 25 years[J].J Am Coll Cardiol,1996,28(3):616 -26.
  • 4Zou Y,Dietrich H,Hu Y,et al.Mouse model of venous bypass graft arteriosclerosis[J].Am J Pathol,1998,153 (4):1301-10.
  • 5Owens C D,Rybicki F J,Dimitrios A S,et al.Early remodeling of lower extremity vein grafts:inflammation influences biomechanical adaptation[J].Vasc Surg,2008,47 (6):1235-42.
  • 6Lath F,Jones S,Zarins C K,et al.Relative contribution of wall shear stress and injury in experimental intimal thickening at PTFE end-to-side arterial anastomoses[J].J Biomech Eng,2002,124(1):44-51.
  • 7Masuda H,Kawamum K,Nanjo H,et al.Ultrastructure of endothelial cells under flow alteration[J].Microsc Res Tech,2003,60(1):2-12.
  • 8武翠华,齐法莲,陈世敏,周京风,杨道理.体外循环心脏手术前后患者血清CRP、CP和PA含量的观察[J].上海免疫学杂志,1999,19(5):299-300. 被引量:7
  • 9杜同信,王自正,王书奎,傅雷,罗骏.冠心病患者血浆BNP、HCY、CRP水平变化分析[J].放射免疫学杂志,2003,16(5):312-314. 被引量:6
  • 10卓绮玲,林增文.高敏-CRP——心血管疾病的独立危险因子[J].国外医学(临床生物化学与检验学分册),2004,25(1):72-73. 被引量:40

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部